跳至主要内容
临床试验/NCT07361549
NCT07361549尚未招募2 期

Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment: A Randomized, Double-Blinded, Parallel Phase 2 Clinical Trial

Daniel A Tonetti, MD1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2026年3月1日最近更新:
干预措施

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
Change in Headache Impact Test-6 Scores

研究概览

简要总结

The goal of this clinical trial is to test whether injecting lidocaine into two blood vessels of the brain can help treat chronic headaches (migraines)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or above
  • Referred for diagnostic angiography
  • Diagnosis of intractable migraine
  • Written informed consent able to be obtained from subject

排除标准

  • Baseline HIT-6 score less than 60 (severe)
  • Pregnant, breastfeeding, or unwilling to practice contraception during participation in the study
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
  • Concomitant intracranial pathology (eg, intracranial malignancy)
  • Known hypersensitivity and/or contraindication to lidocaine or local anesthetics of the amide type
  • Taking chronic medications that, when co-administered with lidocaine and other local anesthetics, are at increased risk of developing methemoglobinemia (nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, acetaminophen, metoclopramide, quinine, sulfasalazine)
  • Known contraindications for angiography (eg, ESRD not requiring hemodialysis). Patients with contrast allergy with be premeditated with diphenhydramine and steroids.
  • Contraindication to anesthetic agents used for conscious sedation/monitored anesthesia care (MAC)
  • Concurrent participation in another research protocol for investigation of an experimental therapy
  • Per DSA imaging, presence of a cerebrovascular pathology known to cause headache (eg, arteriovenous malformation, dural arteriovenous fistula)
  • Per DSA imaging, presence of anastomosis or anatomical variation (eg, branches of middle meningeal artery) that could lead to increased procedural risk
  • Per DSA imaging, lack of endovascular access to either middle meningeal artery, or origin of the middle meningeal artery other than from the external carotid artery
  • Known or suspected inability to adhere to study protocol or protocol requirements, as per discretion of the Investigator or treating provider

研究组 & 干预措施

Treatment

Experimental

Intra-arterial lidocaine

干预措施: Lidocaine (drug) (Drug)

Sham

Sham Comparator

Intra-arterial saline

干预措施: Saline (Drug)

结局指标

主要结局

Change in Headache Impact Test-6 Scores

时间窗: From baseline to 4 week follow-up

Difference in Headache Impact Test-6 Scores, with larger decreases in scores correlating with improvement in symptoms

次要结局

未报告次要终点

研究者

发起方
Daniel A Tonetti, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Daniel A Tonetti, MD

Assistant Professor of Neurological Surgery

The Cooper Health System

研究点 (1)

Loading locations...

相似试验